Clinical management of tinnitus


Annals of Medical Research, vol.140, no.7, pp.553-557, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 140 Issue: 7
  • Publication Date: 2020
  • Doi Number: 10.1080/00016489.2020.1749724
  • Journal Name: Annals of Medical Research
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.553-557
  • Keywords: Botulinum toxin, diagnosis, myoclonus, Palate, tinnitus
  • Karadeniz Technical University Affiliated: Yes


Background: Palatal myoclonic tinnitus (PMT) is a rare otological condition caused by rhythmic contractions of soft palate muscles. Due to its rarity, only a few case series studies have been reported in the literature at the present time. Aims: This large case series study reviews treatment outcomes of PMT patients over the past 15 years based on clinical characteristics. Materials and methods: Between the year 2003 and 2018, 54 patients with a diagnosis of PMT were assessed. Clinical characteristics, audiological findings, psychological status, and other relevant medical history were thoroughly reviewed. Response to various treatment modalities were retrospectively analyzed. Results: The mean age of enrolled patients was 29.0 +/- 16.4 years, with female gender predominance. All of the patients complained of 'clicky' sounding tinnitus. Twenty-nine patients had comorbid tinnitus of other type. Reassurance and behavior therapy was sufficient for young patients. Medication was effective in 44.4% of the patients. Botulinum toxin injection in the palate led to complete resolution of symptoms in a majority of intractable PMT patients. Conclusions and significance: Management of PMT should be customized according to the individual clinical characteristics of the patients. This study may provide insightful information to establish optimal treatment modalities for PMT.